Fonte: International Business Times
The latest agreements involve Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB. President Donald Trump has expanded his push to lower prescription drug prices with agreements involving nine additional pharmaceutical companies, bringing 26 manufacturers into a program that the administration says now covers 89% of the U. S.
Ler na Fonte
Notícias Relacionadas